Neogen Chemicals

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE136S01016
  • NSEID: NEOGEN
  • BSEID: 542665
INR
1,330.00
-25.2 (-1.86%)
BSENSE

Mar 20

BSE+NSE Vol: 42.36 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
615.41
574.74
491.03
482.27
330.45
243.72
223.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
615.41
574.74
491.03
482.27
330.45
243.72
223.82
Raw Material Cost
473.30
341.91
337.43
402.92
235.43
128.49
165.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-143.63
-26.35
-67.02
-136.63
-50.66
16.72
-31.12
Employee Cost
69.88
46.53
47.24
34.00
22.60
15.31
13.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
122.49
112.71
99.11
102.94
63.13
37.34
33.94
Total Expenditure (Excl Depreciation)
522.04
474.80
416.76
403.23
270.50
197.86
181.57
Operating Profit (PBDIT) excl Other Income
93.37
99.94
74.27
79.04
59.95
45.86
42.25
Other Income
5.16
3.42
5.26
2.72
0.22
0.11
0.09
Operating Profit (PBDIT)
98.53
103.36
79.53
81.76
60.17
45.97
42.34
Interest
53.66
36.00
32.37
19.61
14.06
10.27
9.03
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
44.87
67.36
47.16
62.15
46.11
35.70
33.31
Depreciation
19.92
21.03
17.01
11.91
7.89
5.05
3.53
Profit Before Tax
25.06
46.41
30.24
50.22
38.22
30.65
29.79
Tax
7.88
14.06
11.58
14.66
9.34
8.97
8.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.07
32.27
18.57
35.58
28.89
21.68
21.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.07
32.27
18.57
35.58
28.89
21.68
21.27
Share in Profit of Associates
0.25
0.15
0.16
0.08
0.10
0.33
0.08
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.32
32.42
18.73
35.66
28.99
22.01
21.35
Equity Capital
26.38
26.38
26.38
24.94
23.33
23.33
23.33
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
1.4
3.8
0.41
5.89
4.49
3.66
3.46
Operating Profit Margin (Excl OI)
15.17%
17.39%
15.13%
16.39%
18.14%
18.82%
18.88%
Gross Profit Margin
7.29%
11.72%
9.6%
12.89%
13.95%
14.65%
14.88%
PAT Margin
2.77%
5.61%
3.78%
7.38%
8.74%
8.9%
9.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 7.08% vs 17.05% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is -46.58% vs 73.09% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is -6.57% vs 34.56% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 49.06% vs 11.21% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Neogen Chemicals With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
615.41
1,791.02
-1,175.61
-65.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
615.41
1,791.02
-1,175.61
-65.64%
Raw Material Cost
473.30
1,080.49
-607.19
-56.20%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-143.63
-75.79
-67.84
-89.51%
Employee Cost
69.88
93.12
-23.24
-24.96%
Power Cost
0.00
117.71
-117.71
-100.00%
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
122.49
177.00
-54.51
-30.80%
Total Expenditure (Excl Depreciation)
522.04
1,392.53
-870.49
-62.51%
Operating Profit (PBDIT) excl Other Income
93.37
398.49
-305.12
-76.57%
Other Income
5.16
15.55
-10.39
-66.82%
Operating Profit (PBDIT)
98.53
414.04
-315.51
-76.20%
Interest
53.66
56.16
-2.50
-4.45%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
44.87
357.88
-313.01
-87.46%
Depreciation
19.92
126.60
-106.68
-84.27%
Profit Before Tax
25.06
231.24
-206.18
-89.16%
Tax
7.88
-19.80
27.68
139.80%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
17.07
251.08
-234.01
-93.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
17.07
251.08
-234.01
-93.20%
Share in Profit of Associates
0.25
-0.06
0.31
516.67%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.32
251.02
-233.70
-93.10%
Equity Capital
26.38
43.14
-16.76
-38.85%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
7.29%
19.98%
0.00
-12.69%
PAT Margin
2.77%
14.02%
0.00
-11.25%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 615.41 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 7.08% vs 17.05% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 17.32 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -46.58% vs 73.09% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 93.37 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -6.57% vs 34.56% in Dec 2024

Nine Monthly - Interest
Interest 53.66 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 49.06% vs 11.21% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.17%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024